checkAd

    Premier Medical Journal Spotlights Covalon’s VALGUARD  121  0 Kommentare A Novel Solution to Long-Standing Problem of Protecting Vascular Access Sites - Seite 3

    Lesen Sie auch


    The Covalon Technologies Stock at the time of publication of the news with a fall of -3,23 % to 1,50CAD on TSX Venture stock exchange (17. Juli 2023, 23:00 Uhr).

    Business Wire (engl.)
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von Business Wire (engl.)
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Premier Medical Journal Spotlights Covalon’s VALGUARD A Novel Solution to Long-Standing Problem of Protecting Vascular Access Sites - Seite 3 Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the publication of an article in the Journal of the Association for Vascular Access (JAVA), titled “Guarding …